Literature DB >> 30711519

Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS.

André Varcianna1, Monika A Myszczynska1, Lydia M Castelli1, Brendan O'Neill1, Yeseul Kim1, Jordan Talbot1, Sophie Nyberg1, Immanuelle Nyamali1, Paul R Heath1, Matthew J Stopford1, Guillaume M Hautbergue1, Laura Ferraiuolo2.   

Abstract

BACKGROUND: Astrocytes regulate neuronal function, synaptic formation and maintenance partly through secreted extracellular vesicles (EVs). In amyotrophic lateral sclerosis (ALS) astrocytes display a toxic phenotype that contributes to motor neuron (MN) degeneration.
METHODS: We used human induced astrocytes (iAstrocytes) from 3 ALS patients carrying C9orf72 mutations and 3 non-affected donors to investigate the role of astrocyte-derived EVs (ADEVs) in ALS astrocyte toxicity. ADEVs were isolated from iAstrocyte conditioned medium via ultracentrifugation and resuspended in fresh astrocyte medium before testing ADEV impact on HB9-GFP+ mouse motor neurons (Hb9-GFP+ MN). We used post-mortem brain and spinal cord tissue from 3 sporadic ALS and 3 non-ALS cases for PCR analysis.
FINDINGS: We report that EV formation and miRNA cargo are dysregulated in C9ORF72-ALS iAstrocytes and this affects neurite network maintenance and MN survival in vitro. In particular, we have identified downregulation of miR-494-3p, a negative regulator of semaphorin 3A (SEMA3A) and other targets involved in axonal maintenance. We show here that by restoring miR-494-3p levels through expression of an engineered miRNA mimic we can downregulate Sema3A levels in MNs and increases MN survival in vitro. Consistently, we also report lower levels of mir-494-3p in cortico-spinal tract tissue isolated from sporadic ALS donors, thus supporting the pathological importance of this pathway in MNs and its therapeutic potential.
INTERPRETATION: ALS ADEVs and their miRNA cargo are involved in MN death in ALS and we have identified miR-494-3p as a potential therapeutic target. FUNDING: Thierry Latran Fondation and Academy of Medical Sciences. Crown
Copyright © 2019. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Astrocytes; Axonal growth; Extracelular vesicles; Gene therapy; Neurodegeneration; miRNA

Mesh:

Substances:

Year:  2019        PMID: 30711519      PMCID: PMC6413467          DOI: 10.1016/j.ebiom.2018.11.067

Source DB:  PubMed          Journal:  EBioMedicine        ISSN: 2352-3964            Impact factor:   8.143


  44 in total

1.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

2.  Impact of normalization on miRNA microarray expression profiling.

Authors:  Sylvain Pradervand; Johann Weber; Jérôme Thomas; Manuel Bueno; Pratyaksha Wirapati; Karine Lefort; G Paolo Dotto; Keith Harshman
Journal:  RNA       Date:  2009-01-28       Impact factor: 4.942

Review 3.  microRNAs at the synapse.

Authors:  Gerhard Schratt
Journal:  Nat Rev Neurosci       Date:  2009-11-04       Impact factor: 34.870

4.  miRNA malfunction causes spinal motor neuron disease.

Authors:  Sharon Haramati; Elik Chapnik; Yehezkel Sztainberg; Raya Eilam; Raaya Zwang; Noga Gershoni; Edwina McGlinn; Patrick W Heiser; Anne-Marie Wills; Itzhak Wirguin; Lee L Rubin; Hidemi Misawa; Clifford J Tabin; Robert Brown; Alon Chen; Eran Hornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-29       Impact factor: 11.205

5.  The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease.

Authors:  Fred De Winter; Tam Vo; Floor J Stam; Liselijn A B Wisman; Peter R Bär; Simone P Niclou; Freek L van Muiswinkel; Joost Verhaagen
Journal:  Mol Cell Neurosci       Date:  2006-05-03       Impact factor: 4.314

6.  A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord.

Authors:  Shinjiro Kaneko; Akio Iwanami; Masaya Nakamura; Akiyoshi Kishino; Kaoru Kikuchi; Shinsuke Shibata; Hirotaka J Okano; Takeshi Ikegami; Ayako Moriya; Osamu Konishi; Chikao Nakayama; Kazuo Kumagai; Toru Kimura; Yasufumi Sato; Yoshio Goshima; Masahiko Taniguchi; Mamoru Ito; Zhigang He; Yoshiaki Toyama; Hideyuki Okano
Journal:  Nat Med       Date:  2006-11-12       Impact factor: 53.440

7.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

Authors:  Lindsey R Fischer; Deborah G Culver; Philip Tennant; Albert A Davis; Minsheng Wang; Amilcar Castellano-Sanchez; Jaffar Khan; Meraida A Polak; Jonathan D Glass
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

8.  Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis.

Authors:  Koji Yamanaka; Seung Joo Chun; Severine Boillee; Noriko Fujimori-Tonou; Hirofumi Yamashita; David H Gutmann; Ryosuke Takahashi; Hidemi Misawa; Don W Cleveland
Journal:  Nat Neurosci       Date:  2008-02-03       Impact factor: 24.884

9.  Astrocytes from familial and sporadic ALS patients are toxic to motor neurons.

Authors:  Amanda M Haidet-Phillips; Mark E Hester; Carlos J Miranda; Kathrin Meyer; Lyndsey Braun; Ashley Frakes; SungWon Song; Shibi Likhite; Matthew J Murtha; Kevin D Foust; Meghan Rao; Amy Eagle; Anja Kammesheidt; Ashley Christensen; Jerry R Mendell; Arthur H M Burghes; Brian K Kaspar
Journal:  Nat Biotechnol       Date:  2011-08-10       Impact factor: 54.908

10.  Discovery of tissue-specific exons using comprehensive human exon microarrays.

Authors:  Tyson A Clark; Anthony C Schweitzer; Tina X Chen; Michelle K Staples; Gang Lu; Hui Wang; Alan Williams; John E Blume
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  58 in total

1.  Astrocyte-Derived Exosomal microRNA miR-200a-3p Prevents MPP+-Induced Apoptotic Cell Death Through Down-Regulation of MKK4.

Authors:  Norshalena Shakespear; Masato Ogura; Junko Yamaki; Yoshimi Homma
Journal:  Neurochem Res       Date:  2020-02-04       Impact factor: 3.996

2.  Adipose-derived stem cells protect motor neurons and reduce glial activation in both in vitro and in vivo models of ALS.

Authors:  Yuri Ciervo; Noemi Gatto; Chloe Allen; Andrew Grierson; Laura Ferraiuolo; Richard J Mead; Pamela J Shaw
Journal:  Mol Ther Methods Clin Dev       Date:  2021-03-27       Impact factor: 6.698

Review 3.  Astrocyte-derived extracellular vesicles: Neuroreparative properties and role in the pathogenesis of neurodegenerative disorders.

Authors:  Raghavendra Upadhya; Winston Zingg; Siddhant Shetty; Ashok K Shetty
Journal:  J Control Release       Date:  2020-04-11       Impact factor: 9.776

Review 4.  Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs.

Authors:  Madeline Halpern; Kristen J Brennand; James Gregory
Journal:  Neurobiol Dis       Date:  2019-08-02       Impact factor: 5.996

5.  A High-throughput and Pathophysiologically Relevant Astrocyte-motor Neuron Co-culture Assay for Amyotrophic Lateral Sclerosis Therapeutic Discovery.

Authors:  Matthew J Stopford; Scott P Allen; Laura Ferraiuolo
Journal:  Bio Protoc       Date:  2019-09-05

6.  Astrocyte-derived extracellular vesicles enhance the survival and electrophysiological function of human cortical neurons in vitro.

Authors:  Changho Chun; Alec S T Smith; Hyejin Kim; Dana S Kamenz; Jung Hyun Lee; Jong Bum Lee; David L Mack; Mark Bothwell; Claire D Clelland; Deok-Ho Kim
Journal:  Biomaterials       Date:  2021-02-03       Impact factor: 12.479

Review 7.  Non-neuronal cells in amyotrophic lateral sclerosis - from pathogenesis to biomarkers.

Authors:  Björn F Vahsen; Elizabeth Gray; Alexander G Thompson; Olaf Ansorge; Daniel C Anthony; Sally A Cowley; Kevin Talbot; Martin R Turner
Journal:  Nat Rev Neurol       Date:  2021-04-29       Impact factor: 42.937

Review 8.  Reactive astrocyte nomenclature, definitions, and future directions.

Authors:  András Lakatos; James P O'Callaghan; Gabor C Petzold; Alberto Serrano-Pozo; Christian Steinhäuser; Andrea Volterra; Giorgio Carmignoto; Carole Escartin; Elena Galea; Amit Agarwal; Nicola J Allen; Alfonso Araque; Luis Barbeito; Ari Barzilai; Dwight E Bergles; Gilles Bonvento; Arthur M Butt; Wei-Ting Chen; Martine Cohen-Salmon; Colm Cunningham; Benjamin Deneen; Bart De Strooper; Blanca Díaz-Castro; Cinthia Farina; Marc Freeman; Vittorio Gallo; James E Goldman; Steven A Goldman; Magdalena Götz; Antonia Gutiérrez; Philip G Haydon; Dieter H Heiland; Elly M Hol; Matthew G Holt; Masamitsu Iino; Ksenia V Kastanenka; Helmut Kettenmann; Baljit S Khakh; Schuichi Koizumi; C Justin Lee; Shane A Liddelow; Brian A MacVicar; Pierre Magistretti; Albee Messing; Anusha Mishra; Anna V Molofsky; Keith K Murai; Christopher M Norris; Seiji Okada; Stéphane H R Oliet; João F Oliveira; Aude Panatier; Vladimir Parpura; Marcela Pekna; Milos Pekny; Luc Pellerin; Gertrudis Perea; Beatriz G Pérez-Nievas; Frank W Pfrieger; Kira E Poskanzer; Francisco J Quintana; Richard M Ransohoff; Miriam Riquelme-Perez; Stefanie Robel; Christine R Rose; Jeffrey D Rothstein; Nathalie Rouach; David H Rowitch; Alexey Semyanov; Swetlana Sirko; Harald Sontheimer; Raymond A Swanson; Javier Vitorica; Ina-Beate Wanner; Levi B Wood; Jiaqian Wu; Binhai Zheng; Eduardo R Zimmer; Robert Zorec; Michael V Sofroniew; Alexei Verkhratsky
Journal:  Nat Neurosci       Date:  2021-02-15       Impact factor: 24.884

Review 9.  Role of brain extracellular vesicles in air pollution-related cognitive impairment and neurodegeneration.

Authors:  Stacia Nicholson; Andrea Baccarelli; Diddier Prada
Journal:  Environ Res       Date:  2021-10-30       Impact factor: 6.498

Review 10.  DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity.

Authors:  Jannigje Rachel Kok; Nelma M Palminha; Cleide Dos Santos Souza; Sherif F El-Khamisy; Laura Ferraiuolo
Journal:  Cell Mol Life Sci       Date:  2021-06-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.